Company / Book Value per Share
Celldex Therapeutics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.921
FY2025
5-year range
$6.911 / $11.254
FY2021-FY2025
Trend
-29.6%
vs FY2024
Sector context
#105 of 159
Health Care
What the data says
At $7.921, Celldex Therapeutics, Inc.'s book value per share ranks #105 of 159 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $1.961 in FY2017 to $28.743 in FY2018.
Based on SEC 10-K filings.
$7.921 in FY2025 with a 5-year CAGR of +8.4%.
Improved from $7.68 to $7.921 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
#105 of 159 in Health CareTop 66% of 159This company $7.921 Sector average $48.296
▼
-83.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.4%, indicating consistent growth.
- In FY2025, book value per share decreased 29.6% year-over-year.
- Ranks #105 out of 159 companies in the Health Care sector.
- Peak book value per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.40 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.921 | -29.6% |
| FY2024 | $11.254 | +46.5% |
| FY2023 | $7.68 | +11.1% |
| FY2022 | $6.911 | -23.0% |
| FY2021 | $8.977 | +69.8% |
| FY2020 | $5.286 | -4.6% |
| FY2019 | $5.54 | -80.7% |
| FY2018 | $28.743 | +1365.5% |
| FY2017 | $1.961 | -10.9% |
| FY2016 | $2.202 | -25.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026